← Leaderboards
Peter D. Adams
Institute For Cancer Research
$32,646,359
Attributed
$32,646,359
Total exposure
24
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$56,310,965 · 26
By mechanism
P01$20,234,291 · 7
U54$19,457,771 · 5
R01$12,173,861 · 5
P30$1,896,741 · 3
R21$1,758,332 · 4
R56$487,500 · 1
Top collaborators
- Bing Ren5 shared
- Gerald S Shadel5 shared
Most similar at Institute For Cancer Research
Same institution · by research overlap
- Jonathan D. Chernoff$26,792,751
- Myung K Shin$1,010,000
- John Burch$2,893,835
- Dietmar J Kappes$16,314,673
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAgingTissuesEpigenetic ProcessCell AgingMolecularPhenotypeSenescenceMalignant NeoplasmsChromatinSignal TransductionIn VivoProgramsEpigenomePreventAgedPathway InteractionsGenesInflammatoryTranscriptomicsHistonesLinkCollaborationsGenetic
Grant awards (83)
Spatial mapping senescent cells across the mouse lifespan by multiplex transcriptomics and epigenomics$2,690,250
U54 · FY2025 · AG · contact PI
Aging as a Risk Factor and Target for Prevention of Liver Cancer$2,530,091
P01 · FY2025 · AG · contact PI
Bioanalysis Core$1,832,249
U54 · FY2025 · AG · contact PI
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells$619,779
R01 · FY2025 · AR · contact PI
Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions$419,931
R01 · FY2025 · AG · contact PI
Core A: Administrative$361,442
P01 · FY2025 · AG · contact PI
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging$361,442
P01 · FY2025 · AG · contact PI
Admin Core$353,920
U54 · FY2025 · AG · contact PI
Genomics$255,114
P30 · FY2025 · CA · contact PI
Cancer Genome & Epigenetics$255,113
P30 · FY2025 · CA · contact PI
Spatial Mapping Senescent Cells Across the Mouse Lifespan by Multiplex Transcriptomics and Epigenomics$198,900
U54 · FY2025 · AG · contact PI
Admin Core$67,423
U54 · FY2025 · AG · contact PI
Spatial mapping senescent cells across the mouse lifespan by multiplex transcriptomics and epigenomics$2,690,250
U54 · FY2024 · AG · contact PI
Aging as a Risk Factor and Target for Prevention of Liver Cancer$2,585,444
P01 · FY2024 · AG · contact PI
Bioanalysis Core$1,835,624
U54 · FY2024 · AG · contact PI
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells$676,107
R01 · FY2024 · AR · contact PI
Defining chromostasis - a candidate regulator of healthy aging and longevity$514,488
R01 · FY2024 · AG · contact PI
Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions$428,501
R01 · FY2024 · AG · contact PI
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging$413,965
P01 · FY2024 · AG · contact PI
Admin Core$352,538
U54 · FY2024 · AG · contact PI
Genomics$261,805
P30 · FY2024 · CA · contact PI
Core A: Administrative$243,107
P01 · FY2024 · AG · contact PI
Cancer Genome & Epigenetics$56,413
P30 · FY2024 · CA · contact PI
Spatial mapping senescent cells across the mouse lifespan by multiplex transcriptomics and epigenomics$2,690,250
U54 · FY2023 · AG · contact PI
Aging as a Risk Factor and Target for Prevention of Liver Cancer$2,585,419
P01 · FY2023 · AG · contact PI
Bioanalysis Core$1,838,478
U54 · FY2023 · AG · contact PI
Defining chromostasis - a candidate regulator of healthy aging and longevity$809,706
R01 · FY2023 · AG · contact PI
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells$607,182
R01 · FY2023 · AR · contact PI
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging$411,553
P01 · FY2023 · AG · contact PI
Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions$393,372
R01 · FY2023 · AG · contact PI
Admin Core$351,626
U54 · FY2023 · AG · contact PI
Genomics$267,074
P30 · FY2023 · CA · contact PI
Core A: Administrative$251,356
P01 · FY2023 · AG · contact PI
Aging as a Risk Factor and Target for Prevention of Liver Cancer$2,595,836
P01 · FY2022 · AG · contact PI
Spatial mapping senescent cells across the mouse lifespan by multiplex transcriptomics and epigenomics$2,566,784
U54 · FY2022 · AG · contact PI
Bioanalysis Core$1,863,498
U54 · FY2022 · AG · contact PI
Defining chromostasis - a candidate regulator of healthy aging and longevity$840,622
R01 · FY2022 · AG · contact PI
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells$599,047
R01 · FY2022 · AR · contact PI
Project 1: Epigenetic stability in senescence and aging$443,051
P01 · FY2022 · AG · contact PI
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging$415,067
P01 · FY2022 · AG · contact PI
Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions$393,372
R01 · FY2022 · AG · contact PI
Genomics$267,074
P30 · FY2022 · CA · contact PI
Core A: Administrative$244,208
P01 · FY2022 · AG · contact PI
Admin Core$125,981
U54 · FY2022 · AG · contact PI
Aging as a Risk Factor and Target for Prevention of Liver Cancer$2,531,382
P01 · FY2021 · AG · contact PI
Defining chromostasis - a candidate regulator of healthy aging and longevity$884,817
R01 · FY2021 · AG · contact PI
Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions$628,610
R01 · FY2021 · AG · contact PI
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells$600,533
R01 · FY2021 · AR · contact PI
Project 1: Epigenetic stability in senescence and aging$443,229
P01 · FY2021 · AG · contact PI
Core A: Administrative$410,419
P01 · FY2021 · AG · contact PI
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging$373,817
P01 · FY2021 · AG · contact PI
Digital Spatial Profiler Analysis Instrument$302,469
S10 · FY2021 · OD · contact PI
Genomics$267,074
P30 · FY2021 · CA · contact PI
A screen for small molecule inhibitors of CCF to suppress senescence-associated inflammation$243,750
R21 · FY2021 · AG · contact PI
Defining chromostasis - a candidate regulator of healthy aging and longevity$807,699
R01 · FY2020 · AG · contact PI
Project 1: Epigenetic stability in senescence and aging$443,455
P01 · FY2020 · AG · contact PI
A screen for small molecule inhibitors of CCF to suppress senescence-associated inflammation$292,500
R21 · FY2020 · AG · contact PI
Genomics$267,074
P30 · FY2020 · CA · contact PI
Transcriptomic and epigenetic regulators of Drosophila heart aging$243,750
R21 · FY2020 · AG · contact PI
Generation of pro-inflammatory cytoplasmic chromatin fragments in senescent cells - from mechanisms to intervention$487,500
R56 · FY2019 · AG · contact PI
Project 1: Epigenetic stability in senescence and aging$443,629
P01 · FY2019 · AG · contact PI
Transcriptomic and epigenetic regulators of Drosophila heart aging$292,500
R21 · FY2019 · AG · contact PI
Project 1: Epigenetic stability in senescence and aging$451,328
P01 · FY2018 · AG · contact PI
EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS$339,362
P01 · FY2012 · AG · contact PI
EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS$349,405
P01 · FY2011 · AG · contact PI
Regulation of Oncogene-Induced Senescence by Wnt-Signaling$195,639
R01 · FY2011 · CA · contact PI
EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS$345,216
P01 · FY2010 · AG · contact PI
Regulation of Oncogene-Induced Senescence by Wnt-Signaling$147,308
R01 · FY2010 · CA · contact PI
EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS$334,801
P01 · FY2009 · AG · contact PI
Regulation of Oncogene-Induced Senescence by Wnt-Signaling$201,690
R01 · FY2009 · CA · contact PI
EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS$326,267
P01 · FY2008 · AG · contact PI
Regulation of Oncogene-Induced Senescence by Wnt-Signaling$323,233
R01 · FY2008 · CA · contact PI
Formation of Heterochromatin and Cellular Senescence Driven by HIRA and ASF 1a$317,554
R01 · FY2007 · GM · contact PI
Formation of Heterochromatin and Cellular Senescence Driven by HIRA and ASF 1a$327,038
R01 · FY2006 · GM · contact PI
A genome-wide screen for regulators of senescence$166,982
R21 · FY2006 · AG · contact PI
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATE$285,600
R01 · FY2005 · GM
A genome-wide screen for regulators of senescence$213,750
R21 · FY2005 · AG
Analysis of a Novel Cancer Pathway Containing PML &HIRA$152,100
R21 · FY2005 · CA
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATE$285,600
R01 · FY2004 · GM
Analysis of a Novel Cancer Pathway Containing PML &HIRA$153,000
R21 · FY2004 · CA
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATE$285,600
R01 · FY2003 · GM
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATE$287,866
R01 · FY2002 · GM
INVESTIGATION OF A PUTATIVE NOVEL CYCLIN/CDK2 SUBSTRATE$292,967
R01 · FY2001 · GM